Document Detail


Geographic variability in human papillomavirus vaccination among U.S. young women.
MedLine Citation:
PMID:  23332332     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Little information is available on geographic disparity of human papillomavirus (HPV) vaccination among women aged 18-26 years in the U.S. Genital HPV is the most common sexually transmitted infection in the U.S. Persistent HPV infection with oncogenic types can cause cervical cancer.
PURPOSE: This study utilized data collected from the 2010 National Health Interview Survey (NHIS). It identified geographic variability and other factors contributing to the disparities in HPV vaccine series initiation in a nationally representative sample of women aged 18-26 years.
METHODS: The study utilized data collected from 1867 women who participated in the Cancer Control Module Supplement of the 2012 NHIS. A multivariable logistic regression model was used to assess characteristics associated with initiation of the HPV series. Analyses were performed in 2012.
RESULTS: After adjusting for other characteristics, women living in the West and North Central/Midwest had 54% and 20% greater odds of initiating the HPV series, respectively, compared with those living in the Northeast. Other factors associated with HPV series initiation were younger age, Hispanic background, being single/never married, childlessness, a history of HPV, and current alcohol use. Factors correlated with failure to initiate the HPV series were: not having insurance, living below the 200% poverty level, not being a high school graduate, not currently using hormone-based birth control, most recent Pap >1 year ago, no regular provider, last clinic visit ≥12 months ago, and never having received the hepatitis B vaccine.
CONCLUSIONS: Results demonstrate disparity in HPV vaccine uptake by region of residence in the U.S. among young women. Further research is needed to understand the factors contributing to this geographic disparity. Evaluation of vaccination policies and practices associated with higher coverage regions might help characterize effective methods to improve HPV vaccination among women aged 18-26 years.
Authors:
Feifei Wei; Page C Moore; Angela L Green
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  American journal of preventive medicine     Volume:  44     ISSN:  1873-2607     ISO Abbreviation:  Am J Prev Med     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-21     Completed Date:  2013-06-27     Revised Date:  2014-02-04    
Medline Journal Info:
Nlm Unique ID:  8704773     Medline TA:  Am J Prev Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  154-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Age Factors
Female
Health Surveys
Healthcare Disparities / statistics & numerical data*
Humans
Logistic Models
Multivariate Analysis
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / administration & dosage*
Socioeconomic Factors
Young Adult
Grant Support
ID/Acronym/Agency:
1UL1RR029884/RR/NCRR NIH HHS; UL1 RR029884/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Papillomavirus Vaccines
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Substance use among military-connected youth: the california healthy kids survey.
Next Document:  Taxes on sugar-sweetened beverages: results from a 2011 national public opinion survey.